Results 161 to 170 of about 10,988 (206)
Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit. [PDF]
Cell Rep MedLiu Q +13 more
europepmc +1 more source
Correction: Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma. [PDF]
J Immunother Cancereuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2023
Oncolytic virotherapy opens up avenues for cancer treatment by selectively targeting the cancer cells and destructs them either through direct lysis or by inducing an immune response in the tumor microenvironment. This platform technology utilizes a diverse range naturally existing or genetically modified oncolytic viruses for their immunotherapeutic ...
Munazza, Fatima +2 more
openaire +3 more sources
Oncolytic virotherapy opens up avenues for cancer treatment by selectively targeting the cancer cells and destructs them either through direct lysis or by inducing an immune response in the tumor microenvironment. This platform technology utilizes a diverse range naturally existing or genetically modified oncolytic viruses for their immunotherapeutic ...
Munazza, Fatima +2 more
openaire +3 more sources
Personalizing Oncolytic Virotherapy
Human Gene Therapy, 2023The use of oncolytic viruses has become an attractive tool in the clinics for the treatment of various tumor types. Such viruses are genetically modified to conditionally replicate in malignant cells while unharming healthy cells. This platform offers a highly specific tumor killing with exceptional safety profiles.
Firas Hamdan +2 more
openaire +2 more sources
Remote Control of Light-Triggered Virotherapy
ACS Nano, 2016 Clinical virotherapy has been successfully approved for use in cancer treatment by the U.S. Food and Drug Administration; however, a number of improvements are still sought to more broadly develop virotherapy.
Pan-Chyr Yang +2 more
exaly +2 more sources
Oncolytic virotherapy as immunotherapy
Science, 2021Recognizing immune responses to oncolytic virotherapy opens the way for new ...
Alan, Melcher +2 more
openaire +2 more sources
Oncolytic Virotherapy in Glioma Tumors [PDF]
International Journal of Molecular Sciences, 2020 Glioma tumors are one of the most devastating cancer types. Glioblastoma is the most advanced stage with the worst prognosis. Current therapies are still unable to provide an effective cure. Recent advances in oncolytic immunotherapy have generated great expectations in the cancer therapy field. The use of oncolytic viruses (OVs) in cancer treatment is
Noémi García-Romero +2 more
exaly +4 more sources
Journal of Vascular and Interventional Radiology, 2013
Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral ...
Daniel Y, Sze +2 more
openaire +2 more sources
Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral ...
Daniel Y, Sze +2 more
openaire +2 more sources
Poxvirus oncolytic virotherapy
Expert Opinion on Biological Therapy, 2019Over the last decade, advances in biological therapies have resulted in remarkable clinical responses for the treatment of some previously incurable cancers. Oncolytic virotherapy is one of these promising novel strategies for cancer therapy. A successful oncolytic virus promotes tumor cell oncolysis and elicits a robust long-term anti-tumor immunity ...
Diana Thomas
exaly +3 more sources
Optimization of Virotherapy for Cancer
Bulletin of Mathematical Biology, 2009Several viruses preferentially infect and replicate in cancer cells by usurping pathways that are defective in the tumor cell population. Such viruses have a potential as oncolytic agents. The aim of tumor virotherapy is that after injection of the replicating virus, it propagates in the tumor cell population with amplification.
Biesecker, Matt +4 more
openaire +2 more sources